接受循环死亡后捐献肝移植的患者具有生存优势
研究比较英国2008至2015年间接受循环死亡后捐献(DCD)肝移植与等待脑死亡后捐献(DBD)肝移植的生存差异,纳入5,825例等待名单患者和3,949例移植患者。结果显示DCD移植后5年生存率低于DBD,但接受DCD供肝者的死亡风险低于继续等待DBD者,尤其在严重肝病患者中获益最大。
要点
- DCD肝移植后5年生存率低于DBD(69.1% vs 78.3%),但接受DCD供肝者的死亡风险低于继续等待DBD者。
- 在等待名单上,接受DCD肝移植者的风险调整死亡风险低于继续等待者(调整HR 0.55)。
- 肝病最严重的患者接受DCD肝移植的生存获益最大(调整HR 0.19)。
核心结论
- 尽管DCD肝移植结局差于DBD肝移植,但接受DCD供肝可提高个体生存率,尤其对于肝病更严重的患者。
- DCD肝移植改善了英国等待名单患者的总体生存,应予以鼓励。
研究设计与样本
- 研究收集了2008年1月1日至2015年12月31日期间在英国注册等待首次成人肝移植的5,825例患者和接受肝移植的3,949例患者的数据。
- 采用Cox回归模型比较2008至2015年间 deceased donor 肝移植后的生存,评估接受DCD供肝与等待潜在DBD供肝对患者生存的影响。
主要发现
- 3,949例肝移植中953例(23%)使用了DCD供者。
- DCD移植后5年生存率低于DBD(69.1% vs 78.3%;p<0.0001;调整HR 1.65;95%CI 1.40-1.94)。
- 等待名单上5,798例患者中1,325例(23%)死亡或未接受移植被移除。
- 接受DCD供肝者的风险调整死亡风险低于继续等待潜在DBD供肝者(调整HR 0.55;95%CI 0.47-0.65)。
- 肝病最严重者生存获益最大(调整HR 0.19;95%CI 0.07-0.50)。
临床怎么用
- 作者认为,对于等待肝移植的患者,接受DCD供肝可提高个体生存率,尤其对于肝病更严重的患者。
- 作者认为,DCD肝移植改善了英国等待名单患者的总体生存,应予以鼓励。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Donation after circulatory death (DCD) in the UK has tripled in the last decade. However, outcomes following DCD liver transplantation are worse than for donation after brainstem death (DBD) liver transplants. This study examines whether a recipient should accept a "poorer quality" DCD organ or wait longer for a "better" DBD organ. METHODS: Data were collected on 5,825 patients who were registered on the elective waiting list for a first adult liver-only transplant and 3,949 patients who received a liver-only transplant in the UK between 1 January 2008 and 31 December 2015. Survival following deceased donor liver transplantation performed between 2008 and 2015 was compared by Cox regression modelling to assess the impact on patient survival of accepting a DCD liver compared to deferring for a potential DBD transplant. RESULTS: A total of 953 (23%) of the 3,949 liver transplantations performed utilised DCD donors. Five-year post-transplant survival was worse following DCD than DBD transplantation (69.1% [DCD] vs. 78.3% [DBD]; p <0.0001: adjusted hazard ratio [HR] 1.65; 95% CI 1.40-1.94). Of the 5,798 patients registered on the transplant list, 1,325 (23%) died or were removed from the list without receiving a transplant. Patients who received DCD livers had a lower risk-adjusted hazard of death than those who remained on the waiting list for a potential DBD organ (adjusted HR 0.55; 95% CI 0.47-0.65). The greatest survival benefit was in those with the most advanced liver disease (adjusted HR 0.19; 95% CI 0.07-0.50). CONCLUSIONS: Although DCD liver transplantation leads to worse transplant outcomes than DBD transplantation, the individual's survival is enhanced by accepting a DCD offer, particularly for patients with more severe liver disease. DCD liver transplantation improves overall survival for UK listed patients and should be encouraged. LAY SUMMARY: This study looks at patients who require a liver transplant to save their lives; this liver can be donated by a person who has died either after their heart has stopped (donation after cardiac death [DCD]) or after the brain has been injured and can no longer support life (donation after brainstem death [DBD]). We know that livers donated after brainstem death function better than those after cardiac death, but there are not enough of these livers for everyone, so we wished to help patients decide whether it was better for them to accept an early offer of a DCD liver than waiting longer to receive a "better" liver from a DBD donor. We found that patients were more likely to survive if they accepted the offer of a liver transplant as soon as possible (DCD or DBD), especially if their liver disease was very severe.
引用
- Taylor R, Allen E, Richards JA, et al. Survival advantage for patients accepting the offer of a circulatory death liver transplant. J Hepatol. 2019. PMID: 30639505. doi:10.1016/j.jhep.2018.12.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。